HIGHEST QUALITY
Premium-Grade Peptides for Sale
At Ziol Lab Peptides, we’re committed to providing researchers with the highest quality peptides and peptide blends in the industry. All products on this website are intended for research and development purposes only and are not for human consumption.
Every worry, answered with proof you can open.
Every claim here points to proof you can open — not our word for it.
What’s on the label, in the vial
Every batch is identity-confirmed by LC-MS and purity-checked by HPLC before it ships, so the compound and purity are verified against the label — for laboratory research use only.
A COA on every batch
Every order includes that batch’s Certificate of Analysis, and the lot on your vial matches the report — so you can check the compound and purity against an independent third-party test.
The tested sample is your vial
The whole batch is homogenized into one solution, machine-filled to a single dose, and sampled across the run — so your vial reads the same as the one tested.
Tirzepatide
| PRODUCTS |
Tirzepatide – 30mg
|
Retatrutide – 12mg
|
Glow – 70mg
|
|||
|---|---|---|---|---|---|---|
| Company | Ziol Lab Peptides | Typical Competitor | Ziol Lab Peptides | Typical Competitor | Ziol Lab Peptides | Typical Competitor |
| Price | $170.00 | $305.00 | $150.00 | $270.00 | $150.00 | $270.00 |
| Purity | ≥99.874% | 99.3% | ≥99.877% | 98–99.0% | ≥99.832% | 98–99.6% |
| Quantity | 30mg | 15mg | 12mg | 12mg | 70mg (Blend) | 60mg (Blend) |
| Shipping | Free 2-Day Shipping | 3-10 Business Day | Free 2-Day Shipping | 3-10 Business Day | Free 2-Day Shipping | 3-10 Business Day |

Tirzepatide – 30mg
Classification: First-in-class dual GIP and GLP-1 receptor agonist.
Mechanism: A single molecule that simultaneously activates two incretin pathways.
Research Focus: Heavily studied in peptide research for its impact on appetite signaling, insulin response, and body-weight regulation.
Shop Now
Retatrutide -12mg
Classification: First-in-class triple receptor agonist.
Mechanism: A single molecule that simultaneously activates GIP, GLP-1, and glucagon receptors.
Primary Effects:
GIP and GLP-1 drive appetite reduction.
Glucagon increases energy expenditure.
Shop Now















